Citigroup’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-141,685
Closed -$1.58M 5974
2025
Q1
$1.58M Buy
141,685
+95,938
+210% +$1.06M ﹤0.01% 2912
2024
Q4
$471K Buy
45,747
+6,384
+16% +$61.7K ﹤0.01% 3873
2024
Q3
$374K Buy
39,363
+24,187
+159% +$209K ﹤0.01% 3917
2024
Q2
$129K Buy
15,176
+3,277
+28% +$30K ﹤0.01% 4096
2024
Q1
$110K Buy
11,899
+3,290
+38% +$28.9K ﹤0.01% 4249
2023
Q4
$83.5K Buy
8,609
+5,431
+171% +$50.7K ﹤0.01% 4276
2023
Q3
$28.5K Sell
3,178
-8,183
-72% -$77.7K ﹤0.01% 4295
2023
Q2
$127K Sell
11,361
-38,584
-77% -$342K ﹤0.01% 4118
2023
Q1
$524K Buy
49,945
+45,419
+1,004% +$500K ﹤0.01% 3098
2022
Q4
$43.8K Sell
4,526
-726
-14% -$8.18K ﹤0.01% 4318
2022
Q3
$65K Sell
5,252
-2,411
-31% -$29.4K ﹤0.01% 4282
2022
Q2
$78K Buy
7,663
+524
+7% +$5.79K ﹤0.01% 4343
2022
Q1
$91K Buy
7,139
+1,390
+24% +$21.2K ﹤0.01% 4461
2021
Q4
$120K Buy
+5,749
New +$116K ﹤0.01% 4639

Other funds holding ENFN

Citigroup's ENFN Position: Q2 2025 in Review

Citigroup sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 141,685 shares — an estimated $1.58M sold.

Citigroup first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $1.58M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Citigroup reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Citigroup sold 141,685 Enfusion, Inc. shares in Q2 2025, an estimated $1.58M.
  • Citigroup first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Citigroup's Enfusion, Inc. position peaked at $1.58M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.